Preclinical testing reveals tumor growth inhibition via microenvironment-responsive hollow MnO2 nanoshells, highlighting enhanced efficacy in combination checkpoint blockade.
nanoshells able to modulate the tissue microenvironment, release a drug and inhibit tumor growth alone or in combination with check-point blockade therapy.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: